These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10733482)

  • 1. Response to methotrexate in early rheumatoid arthritis is associated with a decrease of T cell derived tumour necrosis factor alpha, increase of interleukin 10, and predicted by the initial concentration of interleukin 4.
    Rudwaleit M; Yin Z; Siegert S; Grolms M; Radbruch A; Braun J; Sieper J
    Ann Rheum Dis; 2000 Apr; 59(4):311-4. PubMed ID: 10733482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methrotexate Treatment Inmunomodulates Abnormal Cytokine Expression by T CD4 Lymphocytes Present in DMARD-Naïve Rheumatoid Arthritis Patients.
    Monserrat Sanz J; Bohórquez C; Gómez AM; Movasat A; Pérez A; Ruíz L; Diaz D; Sánchez AI; Albarrán F; Sanz I; Álvarez-Mon M
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of a Type 2-Polarized T Cell Phenotype With Methotrexate Nonresponse in Patients With Rheumatoid Arthritis.
    Slauenwhite D; McAlpine SM; Hanly JG; Malik A; Haidl ID; Marshall JS; Issekutz TB
    Arthritis Rheumatol; 2020 Jul; 72(7):1091-1102. PubMed ID: 32039570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha.
    Baeten D; Van Damme N; Van den Bosch F; Kruithof E; De Vos M; Mielants H; Veys EM; De Keyser F
    Ann Rheum Dis; 2001 Aug; 60(8):750-5. PubMed ID: 11454638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis.
    Schuerwegh AJ; van Offel JF; Bridts CH; Stevens WJ; De Clerck LS
    J Rheumatol; 2001 Aug; 28(8):1793-9. PubMed ID: 11508581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate preferentially affects Tc1 and Tc17 subset of CD8 T lymphocytes.
    Sandhu A; Ahmad S; Kaur P; Bhatnagar A; Dhawan V; Dhir V
    Clin Rheumatol; 2019 Jan; 38(1):37-44. PubMed ID: 29464523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel predictor of clinical response to methotrexate in patients with rheumatoid arthritis: a pilot study of in vitro T cell cytokine suppression.
    Haroon N; Srivastava R; Misra R; Aggarwal A
    J Rheumatol; 2008 Jun; 35(6):975-8. PubMed ID: 18464312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism.
    Rudwaleit M; Siegert S; Yin Z; Eick J; Thiel A; Radbruch A; Sieper J; Braun J
    Ann Rheum Dis; 2001 Jan; 60(1):36-42. PubMed ID: 11114280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunological biomarker to predict MTX response in early RA.
    Ponchel F; Goëb V; Parmar R; El-Sherbiny Y; Boissinot M; El Jawhari J; Burska A; Vital EM; Harrison S; Conaghan PG; Hensor E; Emery P
    Ann Rheum Dis; 2014 Nov; 73(11):2047-53. PubMed ID: 23989988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of therapy with chimeric monoclonal tumour necrosis factor-alpha antibodies on intracellular cytokine profiles of T lymphocytes and monocytes in rheumatoid arthritis patients.
    Schuerwegh AJ; Van Offel JF; Stevens WJ; Bridts CH; De Clerck LS
    Rheumatology (Oxford); 2003 Apr; 42(4):541-8. PubMed ID: 12649401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of methotrexate (MTX) on expression of signalling lymphocytic activation molecule (SLAM) in patients with rheumatoid arthritis (RA) and its role in the regulation of cytokine production.
    Morita Y; Fukazawa T; Hirashima M; Kaga K; Kusaoi M; Morita T; Touyama S; Morita K; Takasaki Y; Hashimoto H
    Scand J Rheumatol; 2006; 35(4):268-72. PubMed ID: 16882589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized double-blind placebo-controlled study.
    Buondonno I; Rovera G; Sassi F; Rigoni MM; Lomater C; Parisi S; Pellerito R; Isaia GC; D'Amelio P
    PLoS One; 2017; 12(6):e0178463. PubMed ID: 28582403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis.
    Gupta V; Katiyar S; Singh A; Misra R; Aggarwal A
    Int J Rheum Dis; 2018 Aug; 21(8):1548-1556. PubMed ID: 30146748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of methotrexate on the increased CCR2 density on circulating CD4 T lymphocytes and monocytes in active chronic rheumatoid arthritis, with a down regulation only on monocytes in responders.
    Ellingsen T; Hornung N; Møller BK; Poulsen JH; Stengaard-Pedersen K
    Ann Rheum Dis; 2007 Feb; 66(2):151-7. PubMed ID: 16905577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 7 stimulates tumour necrosis factor alpha and Th1 cytokine production in joints of patients with rheumatoid arthritis.
    van Roon JA; Glaudemans KA; Bijlsma JW; Lafeber FP
    Ann Rheum Dis; 2003 Feb; 62(2):113-9. PubMed ID: 12525379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors.
    Aeberli D; Seitz M; Jüni P; Villiger PM
    Rheumatology (Oxford); 2005 Feb; 44(2):172-5. PubMed ID: 15509629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune suppressive effect of dexamethasone in rheumatoid arthritis is accompanied by upregulation of interleukin 10 and by differential changes in interferon gamma and interleukin 4 production.
    Verhoef CM; van Roon JA; Vianen ME; Lafeber FP; Bijlsma JW
    Ann Rheum Dis; 1999 Jan; 58(1):49-54. PubMed ID: 10343540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis.
    Hobl EL; Mader RM; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Kalipciyan M; Jilma B
    Clin Exp Rheumatol; 2011; 29(6):963-9. PubMed ID: 22133036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.